✦ LIBER ✦

Movement disorders and abuse potential of the selective serotonin reuptake inhibitors

✍ Scribed by B. E. Leonard

Publisher: John Wiley and Sons
Year: 1999
Tongue: English
Weight: 82 KB
Volume: 14
Category: Article
ISSN: 0885-6222
DOI: 10.1002/(sici)1099-1077(199901)14:1<1::aid-hup38>3.0.co;2-l

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Treatment of severe depression with the

Treatment of severe depression with the selective serotonin reuptake inhibitors

✍ Alan F. Schatzberg 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 120 KB 👁 2 views

The selective serotonin reuptake inhibitors (SSRIs) are recognized as effective as and better tolerated than older antidepressant therapies and have become the drugs of choice in the treatment of mild to moderate depression. However, there is a clinical impression that the SSRIs are less effective t

Selective serotonin reuptake inhibitors

Selective serotonin reuptake inhibitors and withdrawal symptoms: a review of the literature

✍ François Therrien; John S. Markowitz 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 175 KB 👁 2 views

There are accumulating reports of withdrawal symptoms emerging following the discontinuation of selective serotonin reuptake inhibitor antidepressants. This report summarizes published reports, characterizes the withdrawal syndrome, discusses potential mechanisms of withdrawal, and makes recommendat

Determination of four selective serotoni

Determination of four selective serotonin reuptake inhibitors by capillary isotachophoresis

✍ Tatiana Buzinkaiová; Jozef Polonský 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 53 KB

A review of the safety of selective sero

A review of the safety of selective serotonin reuptake inhibitors during pregnancy

✍ David J. Goldstein; Karen Sundell 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 89 KB 👁 1 views

Antidepressant treatment may be desirable or necessary during pregnancy; however, the bene®t of treatment must balance the bene®ts to the mother with any risk to the developing fetus. In order to make educated, patient-speci®c, bene®t-to-risk assessments, an understanding of possible risks associate

THE USE OF SELECTIVE SEROTONIN REUPTAKE

THE USE OF SELECTIVE SEROTONIN REUPTAKE INHIBITORS FOR DEPRESSION AND PSYCHOSIS COMPLICATING DEMENTIA

✍ WILLIAM J. BURKE; VIJAY DEWAN; STEVEN P. WENGEL; WILLIAM H. ROCCAFORTE; GRACE C. 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 102 KB 👁 1 views

This retrospective chart review examines the impact of selective serotonin reuptake inhibitors on 20 patients with both depression and psychosis complicating dementia of the Alzheimer type (DAT) and other dementias. Fifteen of the 20 patients had moderate to marked improvement in depressive and psyc

Milnacipran: The Clinical Properties of

Milnacipran: The Clinical Properties of a Selective Serotonin and Noradrenaline Reuptake Inhibitor (SNRI)

✍ Y. Lecrubier 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 134 KB 👁 1 views

Milnacipran is a novel antidepressant agent which selectively inhibits the reuptake of serotonin and noradrenaline without directly aecting postsynaptic receptor sites. The biochemical and pharmacological pro®le of milnacipran suggested that the drug would be therapeutically eective and well tolerat